Print

Purpose

The purpose of this study is to evaluate the feasibility and safety of using the LUMENA guidance system during clinical procedures in patients undergoing CT-guided needle Placement for kidney, liver, lymph node, abdominal mass and lung ablation/biopsy.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 90 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Provision of signed and dated informed consent form - Stated willingness to comply with all study procedures and availability for the duration of the study - Male or female, ages 18-90 years - Patient referred to Interventional Radiology for CT-guided needle placement for ablation/biopsy.

Exclusion Criteria

  • Patients who are unable to give informed consent themselves or through their parents. - Patients that do not fit into the gantry of the CT scanner. - Patients who are sensitive to radiation exposure such as pregnant women.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Device Feasibility
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
LUMENA Augmented Reality Guidance 		Participants will undergo clinically indicated CT-guided needle placement for ablation or biopsy with use of the LUMENA augmented reality guidance system.
  • Device: LUMENA Guidance System
    LUMENA is an augmented reality needle guidance system that provides real-time visual guidance during CT-guided needle placement procedures.

Recruiting Locations

Mayo Clinic
Jacksonville, Florida 32224
Contact:
Riley Nichols
904-953-7783

More Details

Status
Recruiting
Sponsor
Mayo Clinic

Study Contact

Nic Dybel
904-953-4324
dybel.nicolas@mayo.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.